The Capital Flowing Into Healthcare at Every Layer

Healthcare is one of the most active sectors in CognitionHub's Follow the Money research — and one of the most structurally complex. Investment is moving in two layers at once: clinical infrastructure at Series C and D scale, and administrative overhead at seed and Series A, from overlapping investor networks.

Clinical infrastructure is being funded on conviction, not yet on revenue. Below it, a separate wave of capital is targeting the administrative overhead that has resisted digitisation for decades: claims, scheduling, records.

The two theses are related but distinct. Conflating them produces imprecise diligence.

At the clinical layer: OpenEvidence raised $250M in January 2026 (Thrive Capital, DST Global) to build AI medical search grounded in clinical evidence. Hippocratic AI raised $126M at Series C (CapitalG, General Catalyst, Andreessen Horowitz) deploying patient-facing AI agents trained on clinical protocols.

At the administrative layer: Predoc, Translucent, and Attuned Intelligence each raised within the Follow the Money research window, each targeting a distinct piece of overhead: medical record retrieval, revenue cycle management, and hospital call centre operations. GV led Translucent's Series A. Radical Ventures backed Attuned. Base10 and Northzone backed Predoc.

Hippocratic AI's pricing model is the diligence signal

Hippocratic charges per patient interaction completed, not per seat or software subscription.

When a company's pricing depends on AI delivering an outcome, the AI must actually deliver it. The pricing model is a structural commitment. For PE professionals evaluating AI-native healthcare companies, this is a cleaner signal than any product claim. Seat-based pricing says the product creates value by existing. Outcome-based pricing says the product creates value by working.

OpenEvidence answers a different question: whether hallucination-resistant, evidence-grounded AI for clinicians is a large enough infrastructure problem to fund at Series D scale. Thrive and DST answered yes. The bet is that clinicians require verifiably grounded AI, and the first company to build it at clinical standards owns the position.

Revenue cycle is where the administrative thesis concentrates

Claims get rejected. Records are incomplete. Scheduling bottlenecks create downstream capacity failures. These are structural, recurring, and expensive to operate without AI.

Translucent, backed by GV and NEA, automates revenue cycle management and claims processing. Predoc, backed by Base10 and Northzone, automates medical record retrieval at scale. Attuned Intelligence, backed by Radical Ventures and Threshold Ventures, deploys AI agents for hospital call centre operations: scheduling, referral management, and admin triage.

None are clinical products. None require regulatory approval to practise medicine. They target overhead, not care delivery. Replacing administrative overhead with AI-native infrastructure changes the unit economics of healthcare delivery without touching the clinical relationship.

The clinical and administrative layers require different diligence frameworks

The clinical layer carries regulatory and liability exposure the administrative layer does not. OpenEvidence and Hippocratic AI are building against clinical standards, FDA scrutiny, and professional liability frameworks. The moat is technical and regulatory simultaneously.

The administrative layer's moat is operational: switching costs, workflow integration, and the data advantage that accumulates as the AI processes more records, more claims, and more scheduling decisions over time.

Capital backing both layers simultaneously, from overlapping investor networks, within the same Follow the Money research window, is the pattern worth reading. Healthcare's AI-native investment is not converging on a single thesis. It is tracking the full system.

"Healthcare & MedTech is equally active, with major rounds across multiple stages."

Follow the Money, CognitionHub Research, March 2026

This article is based on data from Follow the Money: AI Native Startups Raising Funds Right Now, CognitionHub Research, March 2026.